source
- Marrow Therapeutics secures $173 million to advance siRNA therapy for sickle cell, targeting CRISPR competitionMarrow Therapeutics announced a $173 million financing round to fund development of its siRNA drug aimed at treating sickle cell disease. The funding comes after FDA approval of two gene therapies…
- EU regulators and industry discuss streamlining combination product oversight at summitAt the AFDO/RAPS Combination Products Summit, a panel of European regulators and industry representatives met to explore ways to simplify the regulatory pathway for combination products in the EU.…